MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 3, 2005; DOI: 10.1124/mol.104.004713


0026-895X/05/6704-1067-1077$20.00
Mol Pharmacol 67:1067-1077, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.004713v1
mol.104.004713v2
67/4/1067    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suhre, W. M.
Right arrow Articles by Wright, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suhre, W. M.
Right arrow Articles by Wright, S. H.
Original Article

Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2

Wendy M. Suhre, Sean Ekins1, Cheng Chang, Peter W. Swaan, and Stephen H. Wright

Department of Physiology, University of Arizona, Tucson, Arizona (W.M.S., S.H.W.); Concurrent Pharmaceuticals, Ft. Washington, Pennsylvania (S.E.); and Department of Pharmaceutical Sciences, University of Maryland at Baltimore, Baltimore, Maryland (C.C., P.W.S.)

Abstract

Organic cation transporters are important for the elimination of many drugs and toxins from the body. In the present study, substrate-transporter interactions were investigated in Chinese hamster ovary cells stably transfected with either the human or rabbit orthologs of the principal organic cation transporter in the kidney, OCT2. IC50 values, ranging from 0.04 µM to >3 mM, for inhibition of [14C]tetraethylammonium transport were determined for more than 30 structurally diverse compounds. Although the two OCT orthologs displayed similar IC50 values for some of these compounds, the majority varied by as much as 20-fold. Marked differences in substrate affinity were also noted when comparing hOCT2 to the closely related homolog hOCT1. These data suggest the molecular determinants of substrate binding differ markedly among both homologous and orthologous OCT transporters. The software package Cerius2 (Accelrys, San Diego, CA) was used to generate a descriptor-based, two-dimensional, quantitative structure-activity relationship (QSAR) to produce a model relating the affinity of hOCT2 to particular physicochemical features of substrate/inhibitor molecules (r2 = 0.81). Comparative molecular field analysis (Tripos, St. Louis, MO) was used to generate three-dimensional QSARs describing the structural basis of substrate binding to hOCT2 and rbOCT2 (q2 = 0.60 and 0.53, respectively, and each with r2 = 0.97). The quality of the models was assessed by their ability to successfully predict the inhibition of a set of test compounds. The current models enabled prediction of OCT2 affinity and may prove useful in the prediction of unwanted drug interactions at the level of the renal secretory process.


Received for publication July 8, 2004.

Accepted for publication January 3, 2005.

Address correspondence to: Dr. Stephen H. Wright, Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ 85724. E-mail: shwright{at}u.arizona.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
G. A. Knudsen, Y. Cheng, R. K. Kuester, M. J. Hooth, and I. G. Sipes
Effects of Dose and Route on the Disposition and Kinetics of 1-Butyl-1-methylpyrrolidinium Chloride in Male F-344 Rats
Drug Metab. Dispos., November 1, 2009; 37(11): 2171 - 2177.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
O. Zolk, T. F. Solbach, J. Konig, and M. F. Fromm
Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser
Drug Metab. Dispos., June 1, 2009; 37(6): 1312 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-K. Lee, M. Reichold, B. Edemir, G. Ciarimboli, R. Warth, H. Koepsell, and F. Thevenod
Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule
Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1504 - F1513.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Cheng, S. H. Wright, M. J. Hooth, and I. G. Sipes
Characterization of the Disposition and Toxicokinetics of N-Butylpyridinium Chloride in Male F-344 Rats and Female B6C3F1 Mice and Its Transport by Organic Cation Transporter 2
Drug Metab. Dispos., April 1, 2009; 37(4): 909 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kaler, D. M. Truong, A. Khandelwal, M. Nagle, S. A. Eraly, P. W. Swaan, and S. K. Nigam
Structural Variation Governs Substrate Specificity for Organic Anion Transporter (OAT) Homologs: POTENTIAL REMOTE SENSING BY OAT FAMILY MEMBERS
J. Biol. Chem., August 17, 2007; 282(33): 23841 - 23853.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Chen, S. Zhang, M. Sorani, and K. M. Giacomini
Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 695 - 700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. M. Pelis, Y. Dangprapai, T. M. Wunz, and S. H. Wright
Inorganic mercury interacts with cysteine residues (C451 and C474) of hOCT2 to reduce its transport activity
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1583 - F1591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Pelis, X. Zhang, Y. Dangprapai, and S. H. Wright
Cysteine Accessibility in the Hydrophilic Cleft of Human Organic Cation Transporter 2
J. Biol. Chem., November 17, 2006; 281(46): 35272 - 35280.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Engel and J. Wang
Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter
Mol. Pharmacol., November 1, 2005; 68(5): 1397 - 1407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhang, N. V. Shirahatti, D. Mahadevan, and S. H. Wright
A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2)
J. Biol. Chem., October 14, 2005; 280(41): 34813 - 34822.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics